Biotage has completed the acquisition of Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences, a life sciences tools platform created by KKR. Astrea’s over 150 employees worldwide will join Biotage, and the company’s production sites in Cambridge, UK, Isle of Man, Boston, USA, and Joliette, Canada become an important part of Biotage’s global presence. Biotage’s expanded portfolio will now include chromatography resins, absorbents, and columns...
LynxDx, a Michigan diagnostics laboratory specializing in prostate cancer screening and risk prediction, acquired liquid handling solutions from INTEGRA Biosciences to streamline its sample preparation for high throughput COVID-19 testing. The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and turnaround times and, ultimately, support timely diagnosis and treatment...
Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics. Software and hardware integrations between the Waters™ PATROL™ UltraPerformance Liquid Chromatography (UPLC™) Process Analysis System and the Sartorius™ Resolute® BioSMB™ multi-column chromatography platform will give bioprocess engineers access...
Merck, a leading science and technology company, invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development and manufacturing process that ensures drugs are safe, efficacious, and meet regulatory requirements. The expansion will create nearly 500 new jobs, bringing Merck’s workforce to over 1,200 employees across the two sites...
The Earlham Institute has been awarded £31.4m from the Biotechnology and Biological Sciences Research Council (BBSRC), part of UKRI, to deliver an ambitious programme of research, develop new technology, and deliver innovation and impact over the next five years. This investment covers two new strategic programmes of research - Cellular Genomics and Decoding Biodiversity - and two National Bioscience Research Infrastructures (NBRIs) - Transformative Genomics and the Earlham Biofoundry...
Have you read a ton of articles on phase contrast microscopy, but still can’t get the full picture? Well then, watch the second movie in the mini-movie series, “Microscopy With ibidi,” for a simple explanation of how this microscopy technique works. In this short movie, we will show you why this microscopy technique is so important for scientists. and how phase contrast makes almost transparent cells clearly visible...
An international team of scientists from The Institute of Cancer Research, London, and the Max Planck Institute for Multidisciplinary Sciences in Germany employed state-of-the-art biochemical and cryo-electron microscopy (cryo-EM) methods to study the spliceosome in intricate detail and answer long standing questions about how it works. The spliceosome operates like a nanobot, processing RNA – genetic instructions copied from DNA – in a key step to allow the building of complex proteins...
The Verder Group is proud to announce the successful acquisition of ERWEKA, a highly regarded German company renowned for its development and manufacturing of premium tablet testing equipment. With this acquisition Verder Scientific further strengthens its position and accelerates the growth trajectory in targeted niche markets with high state of the art equipment...
As the second leading cause of death worldwide, cancer has touched the lives of most Americans. In an effort to improve treatments for patients on Earth by better understanding how cancer spreads, a team of researchers is sending cancer organoids to space in an investigation sponsored by the International Space Station (ISS) National Laboratory. In collaboration with Axiom Space, researchers from the University of California San Diego and the Sanford Stem Cell Institute, will study the properties of cancer stem cells...
With the historically significant SPECORD device from Analytik Jena, a representative of one of the most proven analytical technologies celebrates its 60th birthday. The fact that the SPECORD spectrophotometer is still an important instrument for UV/Vis analysis worldwide is due both to the SPECORD technology, which has grown over decades, and to its continuous further development. This powerful combination is behind its ability to withstand the constantly increasing quality demands of the analysis market...
Elsevier, a leader in global information analytics, has launched EmBiology, a research tool that visualizes a comprehensive landscape of biological relationships, empowering researchers to gain a rapid understanding of disease biology and focus on critical evidence. Powered by Elsevier’s Biology Knowledge Graph, EmBiology draws on a broad and deep database of multiple sources, including over 7.2 million full text journal articles from high impact Elsevier and third-party publishers, 34.5 million abstracts and 430,000 clinical trials...
GenNext Technologies, Inc., a growth-stage company that provides structural biology instrumentation, software, and services, announce that it is collaborating with Emery Pharma, a full-service CRO offering end-to-end biologic drug development support. Through this partnership, GenNext and Emery Pharma will combine forces to provide best-in-class pharmaceutical functional and structural analysis for allosteric and mono-clonal antibody therapeutics...
A new method of controlling the shape of tiny particles about one tenth of the width of human hair could make the technology that powers our daily lives more stable and more efficient, scientists claim. The process, which transforms the structure of microscopic semiconductor materials known as quantum dots, provides industry with opportunities to optimise optoelectronics, energy harvesting, photonics, and biomedical imaging technologies, according to the Cardiff University-led team...
ACHEMA 2024, the World Forum for Chemical Engineering, Process Engineering and Biotechnology and the world’s leading show for the process industries, will take place in Frankfurt am Main, Germany, from 10 to 14 June 2024. Now the Call for Papers for the ACHEMA Congress opens. Submissions are possible until 6 October 2023. The ACHEMA Congress is the meeting place for researchers, developers, expert users and visionaries..
Pantea Razzaghi, Head of Design at Automata explains why scientists are turning to robotics automation tools to ‘do more with less’ and make more effective use of space – increasing throughput and accuracy with the same lab footprint as before. Laboratory design plays an important role in making lab spaces more accessible and efficient for scientists. This is vital as the UK strives to become a life science leader, of a sector aiming to increase productivity, have the flexibility to scale, and bring products to market at pace...
Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies. The vein-on-a-chip model has been developed by scientists at the University of Birmingham and can be used in experiments to understand mechanisms of blood clot formation. The device, described in a recent paper published in Frontiers in Cardiovascular Medicine, is a tiny channel, which includes structures called ‘valves’ that ensure the correct direction of blood flow...
Waters™ Corporation has announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services. With more than 80% of its rapidly growing revenues tied to large molecule applications, Wyatt accelerates Waters’ ability to build a high-growth business in bioanalytical characterization for new modalities...
Exothera has partnered with Quantoom Biosciences ("Quantoom") to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA. The partnership will enable Exothera to be the first CDMO in the world to offer this off-the-shelf process for the continuous production of RNA as a service. Continuous manufacturing of RNA can provide significant advantages in terms of efficiency, productivity, quality control, cost-effectiveness, and scalability.
Discovery Park has appointed an entrepreneur and highly respected Bio-business programme director from Birkbeck (University of London) as their new Head of Innovation. Renos Savva joins the Discovery Park team to identify, support and empower entrepreneurially minded scientists to thrive at Discovery Park’s tailored facilities in Sandwich, Kent...
Join CloudLIMS' complimentary webinar on May 24, 2023, at 10:00 AM PDT to learn how you can protect your lab data from cyberattacks using the security features of a LIMS. CloudLIMS, a leading SaaS company offering a secure, configurable, high-quality Laboratory Information Management System (LIMS), is pleased to announce a complimentary webinar titled “Protecting Your Lab Data? Use LIMS Security Features” on May 24, 2023, at 10:00 AM PDT (1 P.M. EDT) in association with Astrix....
Revvity, Inc. has announced a new license agreement with AstraZeneca for the technology underlying its Pin-point™ base editing system, a next-generation modular gene editing platform with a strong safety profile. Dr. Alan Fletcher, Senior Vice President, Life Sciences at Revvity, said, “Our fundamental goal for the Pin-point platform is to translate the technology from pre-clinical research into the clinic, and ultimately, impact patient lives...
INTEGRA Biosciences’ PIPETBOY acu 2 pipette controller is helping researchers in the Immune Sensing and Signaling Dynamics group/ImmunoHUB at the i3S in Porto, Portugal, to further their research into the role of the aryl hydrocarbon receptor (AHR) in infection and cancer. Research technician Sérgio Marinho explained: “The AHR is used by cells to monitor their microenvironment, providing molecular cues to identify changes in microbial communities or tumor status, as well as allowing the host to react to potential imbalances in homeostasis...
Biotage has completed the acquisition of Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences, a life sciences tools platform created by KKR. Astrea’s over 150 employees worldwide will join Biotage, and the company’s production sites in Cambridge, UK, Isle of Man, Boston, USA, and Joliette, Canada become an important part of Biotage’s global presence. Biotage’s expanded portfolio will now include chromatography resins, absorbents, and columns...
LynxDx, a Michigan diagnostics laboratory specializing in prostate cancer screening and risk prediction, acquired liquid handling solutions from INTEGRA Biosciences to streamline its sample preparation for high throughput COVID-19 testing. The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and turnaround times and, ultimately, support timely diagnosis and treatment...
Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics. Software and hardware integrations between the Waters™ PATROL™ UltraPerformance Liquid Chromatography (UPLC™) Process Analysis System and the Sartorius™ Resolute® BioSMB™ multi-column chromatography platform will give bioprocess engineers access...
Merck, a leading science and technology company, invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development and manufacturing process that ensures drugs are safe, efficacious, and meet regulatory requirements. The expansion will create nearly 500 new jobs, bringing Merck’s workforce to over 1,200 employees across the two sites...
The Earlham Institute has been awarded £31.4m from the Biotechnology and Biological Sciences Research Council (BBSRC), part of UKRI, to deliver an ambitious programme of research, develop new technology, and deliver innovation and impact over the next five years. This investment covers two new strategic programmes of research - Cellular Genomics and Decoding Biodiversity - and two National Bioscience Research Infrastructures (NBRIs) - Transformative Genomics and the Earlham Biofoundry...
Have you read a ton of articles on phase contrast microscopy, but still can’t get the full picture? Well then, watch the second movie in the mini-movie series, “Microscopy With ibidi,” for a simple explanation of how this microscopy technique works. In this short movie, we will show you why this microscopy technique is so important for scientists. and how phase contrast makes almost transparent cells clearly visible...
An international team of scientists from The Institute of Cancer Research, London, and the Max Planck Institute for Multidisciplinary Sciences in Germany employed state-of-the-art biochemical and cryo-electron microscopy (cryo-EM) methods to study the spliceosome in intricate detail and answer long standing questions about how it works. The spliceosome operates like a nanobot, processing RNA – genetic instructions copied from DNA – in a key step to allow the building of complex proteins...
The Verder Group is proud to announce the successful acquisition of ERWEKA, a highly regarded German company renowned for its development and manufacturing of premium tablet testing equipment. With this acquisition Verder Scientific further strengthens its position and accelerates the growth trajectory in targeted niche markets with high state of the art equipment...
As the second leading cause of death worldwide, cancer has touched the lives of most Americans. In an effort to improve treatments for patients on Earth by better understanding how cancer spreads, a team of researchers is sending cancer organoids to space in an investigation sponsored by the International Space Station (ISS) National Laboratory. In collaboration with Axiom Space, researchers from the University of California San Diego and the Sanford Stem Cell Institute, will study the properties of cancer stem cells...
With the historically significant SPECORD device from Analytik Jena, a representative of one of the most proven analytical technologies celebrates its 60th birthday. The fact that the SPECORD spectrophotometer is still an important instrument for UV/Vis analysis worldwide is due both to the SPECORD technology, which has grown over decades, and to its continuous further development. This powerful combination is behind its ability to withstand the constantly increasing quality demands of the analysis market...
Elsevier, a leader in global information analytics, has launched EmBiology, a research tool that visualizes a comprehensive landscape of biological relationships, empowering researchers to gain a rapid understanding of disease biology and focus on critical evidence. Powered by Elsevier’s Biology Knowledge Graph, EmBiology draws on a broad and deep database of multiple sources, including over 7.2 million full text journal articles from high impact Elsevier and third-party publishers, 34.5 million abstracts and 430,000 clinical trials...
GenNext Technologies, Inc., a growth-stage company that provides structural biology instrumentation, software, and services, announce that it is collaborating with Emery Pharma, a full-service CRO offering end-to-end biologic drug development support. Through this partnership, GenNext and Emery Pharma will combine forces to provide best-in-class pharmaceutical functional and structural analysis for allosteric and mono-clonal antibody therapeutics...
A new method of controlling the shape of tiny particles about one tenth of the width of human hair could make the technology that powers our daily lives more stable and more efficient, scientists claim. The process, which transforms the structure of microscopic semiconductor materials known as quantum dots, provides industry with opportunities to optimise optoelectronics, energy harvesting, photonics, and biomedical imaging technologies, according to the Cardiff University-led team...
ACHEMA 2024, the World Forum for Chemical Engineering, Process Engineering and Biotechnology and the world’s leading show for the process industries, will take place in Frankfurt am Main, Germany, from 10 to 14 June 2024. Now the Call for Papers for the ACHEMA Congress opens. Submissions are possible until 6 October 2023. The ACHEMA Congress is the meeting place for researchers, developers, expert users and visionaries..
Pantea Razzaghi, Head of Design at Automata explains why scientists are turning to robotics automation tools to ‘do more with less’ and make more effective use of space – increasing throughput and accuracy with the same lab footprint as before. Laboratory design plays an important role in making lab spaces more accessible and efficient for scientists. This is vital as the UK strives to become a life science leader, of a sector aiming to increase productivity, have the flexibility to scale, and bring products to market at pace...
Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies. The vein-on-a-chip model has been developed by scientists at the University of Birmingham and can be used in experiments to understand mechanisms of blood clot formation. The device, described in a recent paper published in Frontiers in Cardiovascular Medicine, is a tiny channel, which includes structures called ‘valves’ that ensure the correct direction of blood flow...
Waters™ Corporation has announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services. With more than 80% of its rapidly growing revenues tied to large molecule applications, Wyatt accelerates Waters’ ability to build a high-growth business in bioanalytical characterization for new modalities...
Exothera has partnered with Quantoom Biosciences ("Quantoom") to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA. The partnership will enable Exothera to be the first CDMO in the world to offer this off-the-shelf process for the continuous production of RNA as a service. Continuous manufacturing of RNA can provide significant advantages in terms of efficiency, productivity, quality control, cost-effectiveness, and scalability.
Discovery Park has appointed an entrepreneur and highly respected Bio-business programme director from Birkbeck (University of London) as their new Head of Innovation. Renos Savva joins the Discovery Park team to identify, support and empower entrepreneurially minded scientists to thrive at Discovery Park’s tailored facilities in Sandwich, Kent...
Join CloudLIMS' complimentary webinar on May 24, 2023, at 10:00 AM PDT to learn how you can protect your lab data from cyberattacks using the security features of a LIMS. CloudLIMS, a leading SaaS company offering a secure, configurable, high-quality Laboratory Information Management System (LIMS), is pleased to announce a complimentary webinar titled “Protecting Your Lab Data? Use LIMS Security Features” on May 24, 2023, at 10:00 AM PDT (1 P.M. EDT) in association with Astrix....
Revvity, Inc. has announced a new license agreement with AstraZeneca for the technology underlying its Pin-point™ base editing system, a next-generation modular gene editing platform with a strong safety profile. Dr. Alan Fletcher, Senior Vice President, Life Sciences at Revvity, said, “Our fundamental goal for the Pin-point platform is to translate the technology from pre-clinical research into the clinic, and ultimately, impact patient lives...
INTEGRA Biosciences’ PIPETBOY acu 2 pipette controller is helping researchers in the Immune Sensing and Signaling Dynamics group/ImmunoHUB at the i3S in Porto, Portugal, to further their research into the role of the aryl hydrocarbon receptor (AHR) in infection and cancer. Research technician Sérgio Marinho explained: “The AHR is used by cells to monitor their microenvironment, providing molecular cues to identify changes in microbial communities or tumor status, as well as allowing the host to react to potential imbalances in homeostasis...